Ready, Set, Retina

Tracking Geographic Atrophy: Clinical Biomarkers and Imaging Insights

12 min · 29 de oct de 2025
Portada del episodio Tracking Geographic Atrophy: Clinical Biomarkers and Imaging Insights

Descripción

Welcome back to Ready, Set, Retina! In this episode Daniel Epshtein, OD, FAAO, is joined by Carolyn Majcher, OD, FAAO, to discuss a case of geographic atrophy (GA) and review key biomarkers of progression optometrists should be aware of. For the full episode including imaging, head here:  https://eyesoneyecare.com/resources/tracking-geographic-atrophy-clinical-biomarkers-and-imaging-insights/ Ready Set Retina is independently editorial content supported by advertising from Astellas. The information provided in this article does not and is not intended to constitute medical advice; instead, all information, content, materials available herein are for general information purposes only.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Ready, Set, Retina!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

16 episodios

episode Diabetic Re-Entry Retinopathy: Paul Chous, MA, OD, FAAO & Daniel Epshtein, OD, FAAO artwork

Diabetic Re-Entry Retinopathy: Paul Chous, MA, OD, FAAO & Daniel Epshtein, OD, FAAO

On this episode of Ready, Set, Retina, Daniel Epshtein, OD, FAAO, is joined by A. Paul Chous, MA, OD, FAAO, to discuss a case report of diabetic re-entry retinopathy. Watch the full episode with imaging here: https://eyesoneyecare.com/resources/diabetic-re-entry-retinopathy Ready, Set, Retina is independently editorial content supported by advertising from Apellis Pharmaceuticals. The information provided in this article does not and is not intended to constitute medical advice; instead, all information, content, materials available herein are for general information purposes only. Ready Set Retina is independently editorial content supported by advertising from Astellas. The information provided in this article does not and is not intended to constitute medical advice; instead, all information, content, materials available herein are for general information purposes only.

22 de abr de 202516 min